Education
About Us
Working with TipRanks
Follow Us
Cytek Biosciences, Inc. (CTKB)
NASDAQ:CTKB
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 200.45M | $ 193.01M | $ 164.04M | $ 127.95M | $ 92.84M |
| Gross Profit | $ 111.11M | $ 109.43M | $ 100.97M | $ 79.14M | $ 51.71M |
| Operating Income | $ -20.52M | $ -27.84M | $ -1.80M | $ 9.16M | $ 13.66M |
| EBITDA | $ -10.03M | $ -4.41M | $ 9.49M | $ 8.92M | $ 15.37M |
| Net Income | $ -6.02M | $ -12.15M | $ 2.58M | $ 3.00M | $ 19.41M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 277.86M | $ 262.41M | $ 341.15M | $ 364.62M | $ 165.23M |
| Total Assets | $ 499.50M | $ 494.46M | $ 519.48M | $ 463.31M | $ 219.98M |
| Total Debt | $ 17.02M | $ 14.14M | $ 18.09M | $ 0.00 | $ 2.77M |
| Net Debt | $ -81.70M | $ -153.16M | $ -278.51M | $ -364.62M | $ -162.46M |
| Total Liabilities | $ 103.76M | $ 101.39M | $ 93.93M | $ 57.92M | $ 236.01M |
| Stockholders' Equity | $ 395.74M | $ 393.06M | $ 425.30M | $ 405.04M | $ -16.03M |
| Cash Flow | |||||
| Free Cash Flow | $ 21.85M | $ 454.00K | $ -22.10M | $ 266.00K | $ 13.61M |
| Operating Cash Flow | $ 25.38M | $ 5.28M | $ -12.23M | $ 4.63M | $ 15.16M |
| Investing Cash Flow | $ -82.97M | $ -93.89M | $ -55.91M | $ -20.99M | $ -1.55M |
| Financing Cash Flow | $ -15.82M | $ -41.81M | $ 5.51M | $ 213.56M | $ 122.61M |